Symbiotec Pharmalab plans a ₹150 crore IPO to repay debt and expand operations. The company holds a global leadership position in corticost...

India's IPO market is set for a busy week, with 10 companies, including Symbiotec Pharmalab, Skyways Air Services, Hy-Tech Engineers and Lu...

Symbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical ...

Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 1...

Securities and Exchange Board of India approved IPOs of six companies, including Vishvaraj Environment and SAEL Industries. Firms span sect...

Symbiotec Pharmalab, a leading API manufacturer, is planning an IPO. The company targets a valuation of about $1 billion. The IPO aims to r...

Proposals of Tevapharm India Pvt, GMU Infosoft Pvt, U Infosoft Pvt Ltd, and Monsoon Capital LLC, US are also among these nine investment pl...

The government will consider 31 foreign investment proposals, including that of Ratnakar Bank, Novartis Healthcare and HDFC Bank, on Decemb...

'There seems to be a pick-up in deal due diligence activity (especially, inbound deals) but deals are taking longer time to close,' Lahiri ...

The board also cleared 15 foreign direct investment (FDI) proposal worth Rs 2,000 crore, the finance minister said in a statement on Friday.

The Finance Ministry today said it has approved 15 foreign investment proposals totalling Rs 2,000.5 crore and recommended two FDI applicat...

US-based Mylan Inc's Rs 5,168 crore proposal to acquire Agila Specialties Pvt Ltd -- a subsidiary of pharma firm Strides Arcolab -- was cle...

Mylan Inc's over Rs 5,000 crore foreign direct investment proposal and a host of others in the pharmaceutical sector could soon see green l...

Private equity fund Actis is looking to purchase more than 25% stake in cortico steroids maker Symbiotec Pharmalab for around $50 million.

Symbiotec is engaged in research, development, manufacturing and marketing of research-based active pharmaceutical ingredients for corticos...

As part of its plan to expand in the steroids segment, pharmaceutical firm Lupin on Thursday said it has acquired a majority stake in Symbi...

Lupin on Thursday said it has made an equity investment in Symbiotec Pharmalab, a company focused on steroids, for a majority stake, in a b...